Clinical translation of an albumin-binding PET radiotracer 68Ga-NEB

Journal of Nuclear Medicine

Volumn 56, Issue 10, 2015, Pages 1609-1614

  Zhang, Jingjing ^a,b   Lang, Lixin ^b   Zhu, Zhaohui ^a   Li, Fang ^a   Niu, Gang ^b   Chen, Xiaoyuan ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Albumin; Blood pool; First inhuman; Hemangioma; Truncated Evans blue

Indexed keywords

ALBUMIN; GALLIUM 1,4,7 TRIAZACYCLONONANE N,N,N'' TRIACETIC ACID EVANS BLUE GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 68GA-1,4,7-TRIAZACYCLONONANE-N,N',N''-TRIACETIC ACID; ALBUMINOID; COORDINATION COMPOUND;

ARTICLE; BIOACCUMULATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG PROTEIN BINDING; EX VIVO STUDY; HUMAN; IMAGE ANALYSIS; ISOTOPE LABELING; LIVER CELL CARCINOMA; LIVER CYST; LIVER INJURY; LIVER METASTASIS; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; WHOLE BODY PET; ANIMAL; BAGG ALBINO MOUSE; CYCLOTRON; DIFFERENTIAL DIAGNOSIS; FEMALE; IMAGE PROCESSING; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METABOLISM; MOUSE; NORMAL HUMAN; PROCEDURES; RADIATION DOSE; SCINTISCANNING; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

ALBUMINS; ANIMALS; COORDINATION COMPLEXES; CYCLOTRONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER DISEASES; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84943140977     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.159640     Document Type: Article

References (37)

1. Rubin GD, Leipsic J, Joseph Schoepf U, Fleischmann D, Napel S. CT angio-graphy after 20 years: a transformation in cardiovascular disease characterization continues to advance. Radiology. 2014;271:633-652.
2. Hasebroock KM, Serkova NJ. Toxicity of MRI and CT contrast agents. Expert Opin Drug Metab Toxicol. 2009;5:403-416.
3. Subramanian KM. Cardiac blood-pool tracers. J Nucl Med. 1991;32:480-482.
4. 15O. J Nucl Med. 1982;23:1031-1037.
5. 18F]SFB as an alternative to radioactive CO for quantification of blood volume with PET. Contrast Media Mol Imaging. 2013;8:375-381.
6. Hoffend J, Mier W, Schuhmacher J, et al. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo. Nucl Med Biol. 2005;32: 287-292.
7. 68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyop-athy: comparison with cardiac MRI. Mol Imaging Biol. 2013;15:441-449.
8. Okazawa H, Yonekura Y, Fujibayashi Y, et al. Measurement of regional cerebral plasma pool and hematocrit with copper-62-labeled HSA-DTS. J Nucl Med. 1996;37:1080-1085.
9. Anderson CJ, Rocque PA, Weinheimer CJ, Welch MJ. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging. Nucl Med Biol. 1993;20:461-467.
10. 18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET. Bioconjug Chem. 2009;20: 317-321.
11. Niu G, Lang L, Kiesewetter DO, et al. In vivo labeling of serum albumin for PET. J Nucl Med. 2014;55:1150-1156.
12. Gibson JG, Evans WA. Clinical studies of the blood volume. I. Clinical application of a method employing the azo dye "Evans Blue" and the spectropho-tometer. J Clin Invest. 1937;16:301-316.
13. Spahr PF, Edsall JT. Amino acid composition of human and bovine serum mercaptalbumins. J Biol Chem. 1964;239:850-854.
14. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med. 2004;45:1509-1518.
15. Yan J, Manaenko A, Chen S, et al. Role of SCH79797 in maintaining vascular integrity in rat model of subarachnoid hemorrhage. Stroke. 2013;44:1410-1417.
16. 68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem. 2011;22:2415-2422.
17. McBride WJ, D'Souza CA, Sharkey RM, et al. Improved F-18 labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem. 2010;21:1331-1340.
18. McBride WJ, Sharkey RM, Karacay H, et al. A novel method of F-18 radio-labeling for PET. J Nucl Med. 2009;50:991-998.
19. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007;96:417-423.
20. Carlton JE, Hayes RL. Rapid separation of generator-produced gallium-68 from EDTA eluate. Int J Appl Radiat Isot. 1971;22:44-45.
21. Guide for the Care and Use of Laboratory Animals. Bethesda, MD: National Institutes of Health; 1985. NIH publication 85-23.
22. Sun X, Niu G, Yan Y, et al. Phage display-derived peptides for osteosarcoma imaging. Clin Cancer Res. 2010;16:4268-4277.
23. Lassmann M, Chiesa C, Flux G, Bardies M. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting. Eur J Nucl Med Mol Imaging. 2011;38:192-200.
24. 68Ga bombesin antagonist BAY 86-7548 in healthy men. J Nucl Med. 2013;54:867-872.
25. 18F-FPPRGD2: a PET radiopharmaceutical agent for imaging avb3 integrin levels. Radiology. 2011;260:182-191.
26. International Commission on Radiological Protection. The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37:1-332.
27. Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109:1328-1347, quiz 1348.
28. Wang Y, Lang L, Huang P, et al. In vivo albumin labeling and lymphatic imaging. Proc Natl Acad Sci USA. 2015;112:208-213.
29. Giger M, Baumgartner HR, Zbinden G. Toxicological effects of Evans blue and Congo red on blood platelets. Agents Actions. 1974;4:173-180.
30. Goins B, Phillips WT, Klipper R. Blood-pool imaging using technetium-99m-labeled liposomes. J Nucl Med. 1996;37:1374-1379.
31. 2 shine-through effect on diffusion-weighted MR sequences. Eur J Radiol. 2014;83:468-478.
32. Jang HJ, Kim TK, Lim HK, et al. Hepatic hemangioma: atypical appearances on CT, MR imaging, and sonography. AJR. 2003;180:135-141.
33. Caseiro-Alves F, Brito J, Araujo AE, et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol. 2007;17:1544-1554.
34. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radio-graphics. 2009;29:385-402.
35. Hussain SM, Semelka RC. Hepatic imaging: comparison of modalities. Radiol Clin North Am. 2005;43:929-947.
36. Ronaldson PT, Davis TP. Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther Deliv. 2011;2:1015-1041.
37. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med. 2003;9:713-725.